dr. moore on immunotherapy and parp combinations in brca-mutated ovarian cancer
Published 6 years ago • 227 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
2:03
dr. moore on treatment for patients with ovarian cancer who develop resistance to parp inhibitors
-
1:16
dr. moore discusses combinations in ovarian cancer
-
6:25
combinations with parp inhibitors for ovarian cancer
-
2:23
dr. moore on unanswered questions with parp inhibitors in ovarian cancer
-
1:34
dr. moore on challenges with immunotherapy in ovarian cancer
-
1:25
dr. emens on the combination of checkpoint inhibitors and parp inhibitors in ovarian cancer
-
7:40
i/o combination strategies in ovarian cancer
-
2:32
dr. moore on research evaluating repeat exposure to parp inhibition in ovarian cancer
-
2:09
dr. moore on the nova trial for ovarian cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
1:11
dr. backes discusses parp inhibitor combinations in ovarian cancer
-
6:20
parp inhibitors in recurrent ovarian cancer
-
21:52
esmo 2018: dr. moore speaks to exciting parp inhibitor abstracts in ovarian cancer
-
5:28
ongoing parp inhibitor research in ovarian cancer
-
0:56
dr. crane on combinations with parp inhibitors in ovarian cancer
-
4:40
solo-1 and parp inhibitors in ovarian cancer
-
2:20
dr. moore on the results of the nova trial in ovarian cancer
-
0:54
dr. moore on the prevalence of ovarian cancer
-
0:56
dr. levine on combos with parp inhibitors in ovarian cancer